ID   KU-Lu-MPPt3
AC   CVCL_QW81
DR   JCRB; JCRB1792
DR   Wikidata; Q54900685
RX   PubMed=29090354;
RX   PubMed=34796907;
CC   Population: Japanese.
CC   Doubling time: 59.2-74.5 hours (PubMed=29090354).
CC   Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Heterozygous (PubMed=29090354).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C128847; Lung micropapillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
RX   PubMed=29090354; DOI=10.1007/s00432-017-2541-0;
RA   Matsuo Y., Shiomi K., Sonoda D., Mikubo M., Naito M., Matsui Y.,
RA   Yoshida T., Satoh Y.;
RT   "Molecular alterations in a new cell line (KU-Lu-MPPt3) established
RT   from a human lung adenocarcinoma with a micropapillary pattern.";
RL   J. Cancer Res. Clin. Oncol. 144:75-87(2018).
//
RX   PubMed=34796907; DOI=10.3892/or.2021.8230;
RA   Sonoda D., Kamizaki K., Matsuo Y., Aruga K., Mikubo M., Yamashita K.,
RA   Nishita M., Minami Y., Satoh Y.;
RT   "Characterization of morphological alterations in micropapillary
RT   adenocarcinoma of the lung using an established cell line.";
RL   Oncol. Rep. 47:19.1-19.11(2022).
//